RFC
MDGL icon

Russell Frank Company’s Madrigal Pharmaceuticals MDGL Stock Holding History

Russell Frank Company’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$58K Buy
+6,889
New +$57.5K ﹤0.01% 2849
2013
Q4 		– Sell
-140
Closed -$33K – 2935
2013
Q3 		$33K Sell
140
-1
-0.7% -$213 ﹤0.01% 3179
2013
Q2 		$25K Buy
+141
New +$36.8K ﹤0.01% 2975

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Russell Frank Company's MDGL Position: Q1 2016 in Review

Russell Frank Company opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2016: 6,889 shares worth $58K. The stake represents ﹤0.01% of the portfolio and ranks #2849 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in MDGL as recently as Q3 2013.

Russell Frank Company first reported a position in MDGL in Q2 2013 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold MDGL as of Q1 2016.

  • Russell Frank Company held 6,889 shares of Madrigal Pharmaceuticals worth $58K as of Q1 2016.
  • Madrigal Pharmaceuticals was a new Russell Frank Company position in Q1 2016.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2849 holding.
  • Russell Frank Company first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.